With Respiratory Season rapidly approaching the Northern Hemisphere, clinical laboratories must consider diagnostic strategies that produce maximum clinical utility, utilize efficient workflows, and ...
Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...
Respiratory syncytial virus (RSV) is an important cause of acute respiratory infection, lower respiratory tract disease, clinical complications, and death in older adults. There is currently no ...
Over the last few months respiratory health has become a major area of focus within the medical community and beyond, as COVID-19 on takes its toll. However, respiratory conditions have long impacted ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases ...
Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in hospitalized infants under six months of age with respiratory syncytial virus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results